| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Sheath Neoplasms | 20 | 2021 | 33 | 6.280 |
Why?
|
| Alzheimer Disease | 39 | 2022 | 565 | 4.570 |
Why?
|
| Neurofibromatosis 1 | 13 | 2021 | 39 | 4.200 |
Why?
|
| Neuregulin-1 | 16 | 2014 | 20 | 2.920 |
Why?
|
| Neurilemmoma | 8 | 2018 | 26 | 2.710 |
Why?
|
| ras Proteins | 7 | 2021 | 102 | 2.490 |
Why?
|
| Signal Transduction | 21 | 2021 | 2689 | 2.420 |
Why?
|
| Polymorphism, Single Nucleotide | 28 | 2021 | 627 | 2.290 |
Why?
|
| Schwann Cells | 14 | 2019 | 33 | 2.250 |
Why?
|
| Genome-Wide Association Study | 23 | 2018 | 240 | 1.990 |
Why?
|
| Neurofibrosarcoma | 2 | 2021 | 2 | 1.600 |
Why?
|
| Receptor, ErbB-3 | 9 | 2019 | 17 | 1.580 |
Why?
|
| ErbB Receptors | 13 | 2022 | 239 | 1.520 |
Why?
|
| Genetic Predisposition to Disease | 23 | 2018 | 786 | 1.430 |
Why?
|
| Cell Proliferation | 11 | 2021 | 1174 | 1.420 |
Why?
|
| Receptor, ErbB-2 | 9 | 2006 | 128 | 1.330 |
Why?
|
| Receptor, ErbB-4 | 9 | 2022 | 13 | 1.290 |
Why?
|
| Neurofibroma | 4 | 2018 | 11 | 1.260 |
Why?
|
| Cell Movement | 5 | 2021 | 630 | 1.230 |
Why?
|
| Receptors, Immunologic | 6 | 2017 | 72 | 1.230 |
Why?
|
| Genetic Variation | 8 | 2018 | 220 | 1.150 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2021 | 235 | 1.090 |
Why?
|
| tau Proteins | 5 | 2019 | 61 | 1.070 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2018 | 4 | 1.050 |
Why?
|
| Animals | 58 | 2022 | 20880 | 1.000 |
Why?
|
| Noonan Syndrome | 2 | 2021 | 6 | 0.990 |
Why?
|
| Nerve Tissue Proteins | 10 | 2019 | 290 | 0.960 |
Why?
|
| Neurofibromin 1 | 2 | 2021 | 5 | 0.920 |
Why?
|
| Mutation | 10 | 2021 | 1213 | 0.910 |
Why?
|
| Gene Expression | 8 | 2014 | 770 | 0.900 |
Why?
|
| Membrane Proteins | 6 | 2021 | 617 | 0.880 |
Why?
|
| Humans | 90 | 2022 | 68549 | 0.880 |
Why?
|
| Sciatic Nerve | 6 | 2004 | 26 | 0.850 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2021 | 756 | 0.840 |
Why?
|
| Neurons | 11 | 2020 | 881 | 0.830 |
Why?
|
| GABAergic Neurons | 2 | 2019 | 17 | 0.820 |
Why?
|
| Mice | 27 | 2022 | 8474 | 0.810 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2021 | 8 | 0.810 |
Why?
|
| rho-Associated Kinases | 1 | 2021 | 32 | 0.790 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2021 | 37 | 0.790 |
Why?
|
| Genome, Human | 1 | 2021 | 62 | 0.760 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 1851 | 0.750 |
Why?
|
| Membrane Glycoproteins | 8 | 2019 | 370 | 0.730 |
Why?
|
| Hippocampus | 8 | 2019 | 471 | 0.720 |
Why?
|
| Malformations of Cortical Development, Group I | 1 | 2019 | 1 | 0.680 |
Why?
|
| Symporters | 1 | 2019 | 27 | 0.670 |
Why?
|
| Phosphorylation | 9 | 2021 | 1200 | 0.670 |
Why?
|
| Neoplasms | 2 | 2021 | 1664 | 0.670 |
Why?
|
| Disease Models, Animal | 7 | 2018 | 2550 | 0.660 |
Why?
|
| Mutation, Missense | 2 | 2013 | 112 | 0.650 |
Why?
|
| Neurofibromatoses | 3 | 2016 | 3 | 0.650 |
Why?
|
| Carcinogenesis | 1 | 2019 | 124 | 0.640 |
Why?
|
| Tamoxifen | 4 | 2014 | 62 | 0.630 |
Why?
|
| Neural Conduction | 2 | 2017 | 24 | 0.630 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2020 | 304 | 0.600 |
Why?
|
| Nervous System Diseases | 2 | 2012 | 142 | 0.590 |
Why?
|
| Peripheral Nerves | 1 | 2017 | 22 | 0.580 |
Why?
|
| Glioblastoma | 1 | 2020 | 219 | 0.580 |
Why?
|
| Nervous System Neoplasms | 1 | 2015 | 2 | 0.540 |
Why?
|
| Biological Specimen Banks | 3 | 2022 | 38 | 0.530 |
Why?
|
| Genotype | 14 | 2017 | 785 | 0.530 |
Why?
|
| Genes, Neurofibromatosis 1 | 3 | 2018 | 4 | 0.510 |
Why?
|
| Genetic Engineering | 2 | 2012 | 41 | 0.510 |
Why?
|
| Disease Progression | 3 | 2018 | 1037 | 0.510 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2012 | 23 | 0.500 |
Why?
|
| Nerve Growth Factors | 6 | 2006 | 75 | 0.500 |
Why?
|
| Phenotype | 8 | 2021 | 946 | 0.500 |
Why?
|
| Epilepsy | 1 | 2019 | 336 | 0.500 |
Why?
|
| Genomics | 1 | 2015 | 168 | 0.490 |
Why?
|
| Muscle Proteins | 3 | 2013 | 94 | 0.490 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2014 | 10 | 0.480 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 14 | 0.480 |
Why?
|
| Neoplasm Invasiveness | 3 | 2013 | 369 | 0.470 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 467 | 0.470 |
Why?
|
| RNA, Messenger | 16 | 2010 | 1663 | 0.470 |
Why?
|
| Aged | 30 | 2020 | 14842 | 0.450 |
Why?
|
| Chromatography, Liquid | 2 | 2015 | 120 | 0.450 |
Why?
|
| Rats | 21 | 2014 | 5300 | 0.440 |
Why?
|
| Chromosomes, Mammalian | 1 | 2013 | 8 | 0.440 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 139 | 0.440 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2014 | 411 | 0.440 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2014 | 231 | 0.430 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 27 | 0.430 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 236 | 0.430 |
Why?
|
| Epistasis, Genetic | 3 | 2015 | 32 | 0.420 |
Why?
|
| Male | 43 | 2020 | 37283 | 0.420 |
Why?
|
| Aged, 80 and over | 21 | 2020 | 4843 | 0.420 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 1070 | 0.420 |
Why?
|
| Quinazolines | 2 | 2012 | 70 | 0.420 |
Why?
|
| Frontotemporal Dementia | 1 | 2012 | 17 | 0.420 |
Why?
|
| Cell Death | 5 | 2018 | 329 | 0.410 |
Why?
|
| Receptors, Nerve Growth Factor | 5 | 2014 | 20 | 0.410 |
Why?
|
| Case-Control Studies | 13 | 2019 | 1549 | 0.400 |
Why?
|
| Mice, Transgenic | 8 | 2022 | 1033 | 0.390 |
Why?
|
| Myofibrils | 2 | 2001 | 35 | 0.390 |
Why?
|
| Estrogen Antagonists | 1 | 2010 | 10 | 0.380 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2017 | 214 | 0.380 |
Why?
|
| Glioma | 3 | 2014 | 140 | 0.370 |
Why?
|
| Neurofibroma, Plexiform | 3 | 2019 | 4 | 0.370 |
Why?
|
| Protein Isoforms | 6 | 2022 | 246 | 0.370 |
Why?
|
| Apolipoprotein E4 | 6 | 2017 | 31 | 0.370 |
Why?
|
| Cells, Cultured | 11 | 2013 | 2673 | 0.360 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 65 | 0.360 |
Why?
|
| Proteome | 2 | 2021 | 87 | 0.350 |
Why?
|
| Female | 39 | 2020 | 38021 | 0.350 |
Why?
|
| Cell Division | 4 | 2004 | 541 | 0.340 |
Why?
|
| Skin Neoplasms | 3 | 2019 | 375 | 0.340 |
Why?
|
| Growth Substances | 3 | 2004 | 77 | 0.340 |
Why?
|
| Genetic Loci | 3 | 2014 | 59 | 0.340 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 158 | 0.340 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 710 | 0.330 |
Why?
|
| Datasets as Topic | 3 | 2016 | 52 | 0.330 |
Why?
|
| Axotomy | 3 | 2003 | 3 | 0.320 |
Why?
|
| Phospholipase C gamma | 2 | 2019 | 13 | 0.320 |
Why?
|
| Cytoskeletal Proteins | 2 | 2014 | 108 | 0.320 |
Why?
|
| Amyloid beta-Peptides | 6 | 2022 | 191 | 0.320 |
Why?
|
| Risk | 5 | 2016 | 563 | 0.310 |
Why?
|
| Motor Neurons | 2 | 2006 | 98 | 0.300 |
Why?
|
| Brain Chemistry | 3 | 2012 | 173 | 0.300 |
Why?
|
| Phosphoproteins | 2 | 2021 | 202 | 0.300 |
Why?
|
| Apoptosis | 8 | 2021 | 1641 | 0.300 |
Why?
|
| Spinal Cord | 6 | 2014 | 244 | 0.290 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 103 | 0.290 |
Why?
|
| Ganglia, Sympathetic | 2 | 2004 | 4 | 0.290 |
Why?
|
| Alleles | 4 | 2021 | 386 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2004 | 2083 | 0.290 |
Why?
|
| Brain | 8 | 2022 | 2176 | 0.280 |
Why?
|
| CELF1 Protein | 1 | 2016 | 7 | 0.270 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2022 | 223 | 0.270 |
Why?
|
| Cell Differentiation | 5 | 2006 | 1034 | 0.270 |
Why?
|
| Epidermal Growth Factor | 2 | 2006 | 95 | 0.270 |
Why?
|
| Gossypol | 2 | 2017 | 2 | 0.270 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2005 | 1 | 0.270 |
Why?
|
| Nerve Growth Factor | 2 | 2006 | 54 | 0.260 |
Why?
|
| Neurites | 2 | 2004 | 18 | 0.260 |
Why?
|
| Simplexvirus | 2 | 2016 | 26 | 0.260 |
Why?
|
| Apolipoproteins E | 4 | 2015 | 92 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 2791 | 0.250 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2004 | 1 | 0.250 |
Why?
|
| Myocardium | 2 | 2001 | 1204 | 0.250 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2014 | 7 | 0.250 |
Why?
|
| Plaque, Amyloid | 2 | 2014 | 31 | 0.250 |
Why?
|
| Neurons, Afferent | 1 | 2004 | 32 | 0.250 |
Why?
|
| Receptors, Cell Surface | 3 | 2016 | 248 | 0.250 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 61 | 0.250 |
Why?
|
| Autophagy | 4 | 2014 | 208 | 0.240 |
Why?
|
| Quantitative Trait Loci | 4 | 2016 | 35 | 0.240 |
Why?
|
| Ganglia, Spinal | 5 | 2004 | 29 | 0.240 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2019 | 124 | 0.240 |
Why?
|
| Biomarkers | 4 | 2016 | 1593 | 0.240 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2004 | 5 | 0.240 |
Why?
|
| Amyloid beta-Protein Precursor | 5 | 2018 | 115 | 0.240 |
Why?
|
| Middle Aged | 14 | 2020 | 21119 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2013 | 20 | 0.230 |
Why?
|
| Immunohistochemistry | 7 | 2019 | 1174 | 0.230 |
Why?
|
| Clusterin | 2 | 2015 | 13 | 0.230 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2013 | 4 | 0.220 |
Why?
|
| Risk Factors | 11 | 2018 | 5720 | 0.220 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 1293 | 0.220 |
Why?
|
| Immunoblotting | 3 | 2013 | 254 | 0.220 |
Why?
|
| Cell Cycle | 2 | 2015 | 312 | 0.220 |
Why?
|
| Gene Dosage | 2 | 2021 | 47 | 0.220 |
Why?
|
| Linkage Disequilibrium | 5 | 2017 | 91 | 0.220 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 81 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 331 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 195 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 4 | 2010 | 852 | 0.210 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 508 | 0.210 |
Why?
|
| Age of Onset | 6 | 2016 | 188 | 0.200 |
Why?
|
| Genes, Lethal | 1 | 2021 | 16 | 0.200 |
Why?
|
| Lysophospholipids | 1 | 2003 | 209 | 0.200 |
Why?
|
| Muscle Development | 1 | 2001 | 31 | 0.200 |
Why?
|
| DNA Replication | 2 | 2020 | 167 | 0.200 |
Why?
|
| Failure to Thrive | 1 | 2021 | 17 | 0.200 |
Why?
|
| Biology | 1 | 2021 | 14 | 0.200 |
Why?
|
| DNA | 5 | 2005 | 597 | 0.200 |
Why?
|
| Staining and Labeling | 2 | 2019 | 144 | 0.200 |
Why?
|
| Dentate Gyrus | 2 | 2019 | 13 | 0.200 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2021 | 19 | 0.190 |
Why?
|
| Peptide Fragments | 3 | 2016 | 483 | 0.190 |
Why?
|
| Peripheral Nervous System | 2 | 2013 | 12 | 0.190 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 18 | 0.190 |
Why?
|
| Karyotyping | 1 | 2021 | 74 | 0.190 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 3 | 2015 | 7 | 0.190 |
Why?
|
| Sphingosine | 1 | 2003 | 315 | 0.190 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2022 | 106 | 0.190 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2020 | 38 | 0.190 |
Why?
|
| Wallerian Degeneration | 2 | 1998 | 6 | 0.190 |
Why?
|
| eIF-2 Kinase | 1 | 2021 | 49 | 0.190 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2020 | 16 | 0.190 |
Why?
|
| Oncolytic Virotherapy | 3 | 2016 | 15 | 0.180 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 700 | 0.180 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2020 | 2 | 0.180 |
Why?
|
| Ionophores | 1 | 2020 | 25 | 0.180 |
Why?
|
| Pyrans | 1 | 2020 | 16 | 0.180 |
Why?
|
| Homologous Recombination | 1 | 2020 | 13 | 0.180 |
Why?
|
| Receptors, Chemokine | 1 | 2020 | 26 | 0.180 |
Why?
|
| Perforant Pathway | 1 | 2019 | 4 | 0.180 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 159 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 1995 | 614 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2018 | 35 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2010 | 146 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 1 | 2019 | 18 | 0.170 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2019 | 2 | 0.170 |
Why?
|
| Protein Precursors | 1 | 2019 | 105 | 0.170 |
Why?
|
| Transcription, Genetic | 7 | 2001 | 562 | 0.170 |
Why?
|
| Cell Adhesion | 1 | 2000 | 324 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 86 | 0.170 |
Why?
|
| Enzyme Inhibitors | 5 | 2006 | 659 | 0.170 |
Why?
|
| Cell Survival | 4 | 2018 | 901 | 0.160 |
Why?
|
| Neuroglia | 3 | 2005 | 136 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 24 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2015 | 120 | 0.160 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2015 | 10 | 0.160 |
Why?
|
| Chemokines, CXC | 1 | 1998 | 16 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 176 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2022 | 310 | 0.160 |
Why?
|
| Genes, ras | 1 | 2018 | 46 | 0.160 |
Why?
|
| Homozygote | 2 | 2015 | 119 | 0.160 |
Why?
|
| Chemokine CCL2 | 1 | 1998 | 101 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2021 | 621 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2018 | 78 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2006 | 194 | 0.150 |
Why?
|
| Synapses | 1 | 2019 | 222 | 0.150 |
Why?
|
| Nitrophenols | 1 | 2017 | 14 | 0.150 |
Why?
|
| Molecular Mimicry | 1 | 2017 | 13 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2016 | 432 | 0.140 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2017 | 49 | 0.140 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 1996 | 2 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 163 | 0.140 |
Why?
|
| Immunization, Passive | 1 | 1996 | 24 | 0.140 |
Why?
|
| Azathioprine | 1 | 1996 | 16 | 0.140 |
Why?
|
| Neurofibromatosis 2 | 1 | 2016 | 1 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 334 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2018 | 174 | 0.140 |
Why?
|
| Meta-Analysis as Topic | 2 | 2013 | 57 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2017 | 156 | 0.140 |
Why?
|
| Biopsy | 1 | 2018 | 539 | 0.140 |
Why?
|
| Aging | 4 | 2014 | 911 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 78 | 0.140 |
Why?
|
| Pyrroles | 1 | 2017 | 83 | 0.140 |
Why?
|
| Exosomes | 1 | 2016 | 44 | 0.140 |
Why?
|
| Proteolysis | 2 | 2013 | 97 | 0.140 |
Why?
|
| Microglia | 1 | 2017 | 143 | 0.140 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 184 | 0.140 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 35 | 0.140 |
Why?
|
| Cyclosporine | 1 | 1996 | 121 | 0.130 |
Why?
|
| Axons | 1 | 2017 | 139 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2017 | 141 | 0.130 |
Why?
|
| Proteins | 1 | 2019 | 473 | 0.130 |
Why?
|
| Interferons | 1 | 2016 | 36 | 0.130 |
Why?
|
| Gene Frequency | 5 | 2017 | 207 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1140 | 0.130 |
Why?
|
| Cytoprotection | 2 | 2013 | 39 | 0.130 |
Why?
|
| Actins | 2 | 1988 | 249 | 0.130 |
Why?
|
| Mice, SCID | 2 | 2018 | 238 | 0.130 |
Why?
|
| Ganglia | 1 | 1995 | 6 | 0.130 |
Why?
|
| Glycoproteins | 1 | 1997 | 238 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 94 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2016 | 120 | 0.130 |
Why?
|
| Chemokines | 1 | 2015 | 119 | 0.130 |
Why?
|
| Doxycycline | 1 | 2015 | 49 | 0.130 |
Why?
|
| Trifluoperazine | 1 | 2014 | 5 | 0.130 |
Why?
|
| Executive Function | 1 | 2016 | 106 | 0.130 |
Why?
|
| Databases, Genetic | 3 | 2016 | 52 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2019 | 3187 | 0.120 |
Why?
|
| Odds Ratio | 4 | 2017 | 880 | 0.120 |
Why?
|
| Pyrazoles | 1 | 2016 | 190 | 0.120 |
Why?
|
| Receptors, Virus | 1 | 2014 | 20 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 183 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1465 | 0.120 |
Why?
|
| Sulfonylurea Receptors | 1 | 2014 | 1 | 0.120 |
Why?
|
| Oncolytic Viruses | 1 | 2014 | 17 | 0.120 |
Why?
|
| Myelin P0 Protein | 1 | 2014 | 1 | 0.120 |
Why?
|
| Desmin | 1 | 2014 | 13 | 0.120 |
Why?
|
| Spinal Nerve Roots | 1 | 2014 | 9 | 0.120 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2014 | 15 | 0.120 |
Why?
|
| Memory | 1 | 2016 | 214 | 0.120 |
Why?
|
| Infusions, Intraventricular | 1 | 2014 | 8 | 0.120 |
Why?
|
| Phylogeny | 1 | 1995 | 196 | 0.120 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 28 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2019 | 2356 | 0.120 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2014 | 160 | 0.120 |
Why?
|
| Herpesvirus 1, Human | 1 | 2014 | 30 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 267 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 88 | 0.120 |
Why?
|
| Interleukin-12 | 1 | 2014 | 75 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2003 | 195 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 434 | 0.110 |
Why?
|
| Transfection | 1 | 2015 | 782 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 199 | 0.110 |
Why?
|
| Receptors, Neuropeptide | 1 | 2013 | 22 | 0.110 |
Why?
|
| Young Adult | 3 | 2019 | 5710 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2013 | 56 | 0.110 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 10 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 188 | 0.110 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2013 | 30 | 0.110 |
Why?
|
| Base Pairing | 1 | 2013 | 15 | 0.110 |
Why?
|
| Trypsinogen | 1 | 2012 | 7 | 0.110 |
Why?
|
| Claudins | 1 | 2012 | 6 | 0.110 |
Why?
|
| Serine | 1 | 2013 | 99 | 0.110 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 11 | 0.110 |
Why?
|
| Protein Kinase C | 3 | 2013 | 270 | 0.110 |
Why?
|
| Proto-Oncogenes | 1 | 1992 | 37 | 0.110 |
Why?
|
| Trypsin | 1 | 2012 | 64 | 0.110 |
Why?
|
| Dementia | 1 | 2014 | 158 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 514 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2018 | 659 | 0.110 |
Why?
|
| Infant | 1 | 2019 | 2891 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 196 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.100 |
Why?
|
| Chloroquine | 1 | 2012 | 21 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 144 | 0.100 |
Why?
|
| Haplotypes | 1 | 2012 | 174 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2013 | 182 | 0.100 |
Why?
|
| Ligands | 1 | 2013 | 317 | 0.100 |
Why?
|
| Time Factors | 4 | 2004 | 4655 | 0.100 |
Why?
|
| Integrin beta1 | 2 | 2009 | 48 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2013 | 237 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2010 | 954 | 0.100 |
Why?
|
| Antibodies | 1 | 1992 | 241 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2015 | 866 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2013 | 753 | 0.100 |
Why?
|
| Actinin | 2 | 2001 | 9 | 0.100 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 2 | 0.100 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 30 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 1993 | 597 | 0.100 |
Why?
|
| Lysosomes | 1 | 2012 | 136 | 0.100 |
Why?
|
| In Situ Hybridization | 3 | 2001 | 201 | 0.090 |
Why?
|
| Pyrimidines | 3 | 2016 | 178 | 0.090 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1990 | 18 | 0.090 |
Why?
|
| Intestinal Neoplasms | 1 | 1990 | 30 | 0.090 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 2010 | 1 | 0.090 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 138 | 0.090 |
Why?
|
| Chick Embryo | 2 | 2001 | 379 | 0.090 |
Why?
|
| Receptors, Complement 3b | 1 | 2010 | 35 | 0.090 |
Why?
|
| Kinetics | 2 | 2009 | 1047 | 0.090 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2010 | 4 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 18 | 0.090 |
Why?
|
| Inclusion Bodies | 1 | 2010 | 10 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2011 | 230 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 213 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 342 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2009 | 38 | 0.090 |
Why?
|
| Genes | 2 | 1987 | 86 | 0.090 |
Why?
|
| Synaptic Transmission | 2 | 2019 | 236 | 0.090 |
Why?
|
| Laminin | 1 | 2009 | 62 | 0.090 |
Why?
|
| Estrogens | 1 | 2010 | 173 | 0.090 |
Why?
|
| Receptors, Steroid | 2 | 1990 | 13 | 0.090 |
Why?
|
| Neuregulins | 2 | 2001 | 11 | 0.090 |
Why?
|
| Fibronectins | 1 | 2009 | 130 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 58 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 498 | 0.080 |
Why?
|
| Adolescent | 2 | 2019 | 8904 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2009 | 175 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 320 | 0.080 |
Why?
|
| Adult | 4 | 2019 | 21379 | 0.080 |
Why?
|
| Reference Standards | 1 | 2008 | 115 | 0.080 |
Why?
|
| Animals, Newborn | 3 | 2008 | 396 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2005 | 100 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 1990 | 307 | 0.080 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 306 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2008 | 146 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1988 | 43 | 0.080 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2008 | 92 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2008 | 114 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 1990 | 475 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 1745 | 0.080 |
Why?
|
| Liver | 2 | 1990 | 1118 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2022 | 1692 | 0.070 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2008 | 56 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 134 | 0.070 |
Why?
|
| Chemokine CXCL1 | 2 | 2015 | 21 | 0.070 |
Why?
|
| Age Factors | 2 | 2003 | 1860 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2008 | 233 | 0.070 |
Why?
|
| Tritium | 2 | 2003 | 101 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2015 | 682 | 0.070 |
Why?
|
| Brain Neoplasms | 2 | 2014 | 371 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2003 | 88 | 0.070 |
Why?
|
| Zinc Fingers | 1 | 2016 | 17 | 0.070 |
Why?
|
| Chickens | 4 | 1995 | 232 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 1986 | 117 | 0.070 |
Why?
|
| Cadherin Related Proteins | 1 | 2015 | 9 | 0.070 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2015 | 3 | 0.070 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2015 | 12 | 0.070 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2016 | 41 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1988 | 317 | 0.070 |
Why?
|
| Netrin Receptors | 2 | 2016 | 3 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 34 | 0.070 |
Why?
|
| Saposins | 1 | 2015 | 24 | 0.070 |
Why?
|
| Phosphotyrosine | 1 | 2005 | 41 | 0.070 |
Why?
|
| Astrocytoma | 1 | 2005 | 30 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 492 | 0.070 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 47 | 0.070 |
Why?
|
| Cadherins | 1 | 2015 | 93 | 0.060 |
Why?
|
| Receptors, Transferrin | 1 | 2005 | 18 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2015 | 161 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 81 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2015 | 56 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2005 | 58 | 0.060 |
Why?
|
| Superior Cervical Ganglion | 1 | 2004 | 6 | 0.060 |
Why?
|
| Molybdenum | 1 | 1984 | 7 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2005 | 114 | 0.060 |
Why?
|
| Stem Cells | 1 | 2006 | 248 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 1984 | 34 | 0.060 |
Why?
|
| Transferrin | 1 | 2005 | 94 | 0.060 |
Why?
|
| Virus Replication | 2 | 2016 | 104 | 0.060 |
Why?
|
| DNA Damage | 2 | 2021 | 190 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1753 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2005 | 295 | 0.060 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2004 | 1 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 376 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 150 | 0.060 |
Why?
|
| DNA, Neoplasm | 1 | 2004 | 95 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2014 | 219 | 0.060 |
Why?
|
| Ganglia, Autonomic | 1 | 2003 | 10 | 0.060 |
Why?
|
| Nuclease Protection Assays | 1 | 2003 | 1 | 0.060 |
Why?
|
| Trigeminal Ganglion | 1 | 2003 | 5 | 0.060 |
Why?
|
| Lameness, Animal | 1 | 2003 | 3 | 0.060 |
Why?
|
| Thymidine | 1 | 2003 | 32 | 0.060 |
Why?
|
| Colforsin | 1 | 2003 | 42 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2017 | 447 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2003 | 89 | 0.060 |
Why?
|
| Paralysis | 1 | 2003 | 35 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2003 | 189 | 0.060 |
Why?
|
| Hindlimb | 1 | 2003 | 38 | 0.060 |
Why?
|
| Republic of Korea | 1 | 2013 | 23 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2015 | 266 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2013 | 32 | 0.060 |
Why?
|
| Pertussis Toxin | 1 | 2003 | 72 | 0.060 |
Why?
|
| Tyrosine | 1 | 2004 | 196 | 0.060 |
Why?
|
| Japan | 1 | 2013 | 68 | 0.060 |
Why?
|
| Immunochemistry | 1 | 2003 | 17 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 118 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2077 | 0.050 |
Why?
|
| Entorhinal Cortex | 1 | 2003 | 11 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2003 | 115 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 93 | 0.050 |
Why?
|
| Multigene Family | 3 | 2011 | 93 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7028 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 167 | 0.050 |
Why?
|
| Caspases | 2 | 2013 | 194 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 231 | 0.050 |
Why?
|
| Linear Models | 2 | 2015 | 521 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1995 | 95 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 250 | 0.050 |
Why?
|
| LIM Domain Proteins | 1 | 2001 | 15 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2017 | 1082 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 57 | 0.050 |
Why?
|
| Staurosporine | 2 | 2014 | 19 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2021 | 17 | 0.050 |
Why?
|
| Receptors, Cholinergic | 1 | 2001 | 30 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 742 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 200 | 0.050 |
Why?
|
| Astrocytes | 2 | 2020 | 270 | 0.050 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2000 | 2 | 0.050 |
Why?
|
| Base Sequence | 3 | 1995 | 1015 | 0.050 |
Why?
|
| Complement Factor B | 1 | 2000 | 19 | 0.050 |
Why?
|
| Data Warehousing | 1 | 2021 | 21 | 0.050 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2000 | 31 | 0.050 |
Why?
|
| Unfolded Protein Response | 1 | 2021 | 70 | 0.050 |
Why?
|
| Microspheres | 1 | 2020 | 59 | 0.050 |
Why?
|
| Vinculin | 1 | 2000 | 15 | 0.050 |
Why?
|
| Pericytes | 1 | 2022 | 81 | 0.050 |
Why?
|
| Connectin | 1 | 2000 | 14 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2021 | 99 | 0.050 |
Why?
|
| Complement C3 | 1 | 2000 | 101 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2000 | 93 | 0.050 |
Why?
|
| Solvents | 1 | 2020 | 109 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 282 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 294 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2000 | 122 | 0.040 |
Why?
|
| Receptor, trkA | 3 | 1998 | 13 | 0.040 |
Why?
|
| Microbiota | 1 | 2021 | 79 | 0.040 |
Why?
|
| Receptor, trkB | 1 | 2019 | 27 | 0.040 |
Why?
|
| Dopamine | 1 | 2022 | 474 | 0.040 |
Why?
|
| Neurturin | 1 | 2019 | 1 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2000 | 133 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2000 | 99 | 0.040 |
Why?
|
| Chemotactic Factors | 1 | 1998 | 14 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cell Line | 2 | 2021 | 1752 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1998 | 48 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 1998 | 63 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 499 | 0.040 |
Why?
|
| Species Specificity | 1 | 1998 | 302 | 0.040 |
Why?
|
| Pregnancy | 4 | 2006 | 2334 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 512 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 148 | 0.040 |
Why?
|
| Organ Specificity | 2 | 1995 | 167 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 1997 | 29 | 0.040 |
Why?
|
| Exome | 1 | 2017 | 20 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 246 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 30 | 0.040 |
Why?
|
| Peroxisomal Bifunctional Enzyme | 1 | 2017 | 4 | 0.040 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2017 | 17 | 0.040 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2017 | 7 | 0.040 |
Why?
|
| NFI Transcription Factors | 1 | 2017 | 6 | 0.040 |
Why?
|
| Receptors, GABA | 1 | 2017 | 8 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 21 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 230 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 57 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 331 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2017 | 51 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1997 | 251 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 1998 | 176 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 2 | 1993 | 74 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 81 | 0.030 |
Why?
|
| Chromosomes | 1 | 2016 | 17 | 0.030 |
Why?
|
| Models, Biological | 1 | 2000 | 981 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Indoles | 1 | 2017 | 146 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2015 | 18 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 328 | 0.030 |
Why?
|
| Chicago | 1 | 2015 | 30 | 0.030 |
Why?
|
| Nitriles | 1 | 2016 | 68 | 0.030 |
Why?
|
| I-kappa B Kinase | 1 | 2015 | 40 | 0.030 |
Why?
|
| Indiana | 1 | 2015 | 35 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 71 | 0.030 |
Why?
|
| Thiophenes | 1 | 2016 | 76 | 0.030 |
Why?
|
| TATA Box | 1 | 1995 | 7 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 20 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 35 | 0.030 |
Why?
|
| Amides | 1 | 2016 | 86 | 0.030 |
Why?
|
| Piperazines | 1 | 2017 | 206 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 21 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1995 | 88 | 0.030 |
Why?
|
| Protective Factors | 1 | 2015 | 24 | 0.030 |
Why?
|
| Exons | 1 | 1995 | 122 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 86 | 0.030 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2014 | 9 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2014 | 2 | 0.030 |
Why?
|
| Macrophages | 1 | 1998 | 647 | 0.030 |
Why?
|
| Nectins | 1 | 2014 | 1 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 159 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2014 | 23 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2014 | 2 | 0.030 |
Why?
|
| Sulfonylurea Compounds | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 98 | 0.030 |
Why?
|
| Aotidae | 1 | 2014 | 1 | 0.030 |
Why?
|
| Sclerosis | 1 | 2014 | 32 | 0.030 |
Why?
|
| Drug Administration Routes | 1 | 2014 | 25 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2014 | 49 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 71 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 546 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1027 | 0.030 |
Why?
|
| Mitochondria | 1 | 2018 | 643 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1993 | 35 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 326 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1030 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2013 | 144 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 63 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 80 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 82 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2013 | 62 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 142 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 1446 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 384 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2798 | 0.030 |
Why?
|
| Uterus | 1 | 1992 | 77 | 0.030 |
Why?
|
| Autopsy | 1 | 2012 | 56 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 247 | 0.030 |
Why?
|
| Genes, erbB | 1 | 2012 | 1 | 0.030 |
Why?
|
| Iron | 1 | 2014 | 197 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2014 | 332 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2012 | 125 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 193 | 0.020 |
Why?
|
| RNA | 1 | 2012 | 171 | 0.020 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 1990 | 6 | 0.020 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1990 | 4 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1990 | 17 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1990 | 30 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 170 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 517 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 242 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1987 | 49 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1987 | 95 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 1515 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1990 | 222 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 2009 | 28 | 0.020 |
Why?
|
| Fibrinolysin | 1 | 2009 | 33 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2009 | 26 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1265 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 219 | 0.020 |
Why?
|
| Cytokines | 1 | 1993 | 866 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1990 | 284 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 507 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 1074 | 0.020 |
Why?
|
| Troponin | 1 | 1987 | 25 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1988 | 86 | 0.020 |
Why?
|
| Calmodulin | 1 | 1987 | 53 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 3703 | 0.020 |
Why?
|
| Muscles | 1 | 1987 | 158 | 0.020 |
Why?
|
| Telencephalon | 1 | 2006 | 6 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 3256 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 271 | 0.020 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 2 | 1998 | 2 | 0.020 |
Why?
|
| Receptor, trkC | 2 | 1998 | 6 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2006 | 19 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 100 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2006 | 52 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1986 | 357 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2005 | 2 | 0.020 |
Why?
|
| Peroxynitrous Acid | 1 | 2006 | 55 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 140 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 260 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2005 | 37 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 226 | 0.020 |
Why?
|
| Plasmids | 1 | 1986 | 258 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2005 | 99 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 765 | 0.020 |
Why?
|
| Testosterone Congeners | 1 | 1984 | 1 | 0.020 |
Why?
|
| Metribolone | 1 | 1984 | 2 | 0.020 |
Why?
|
| Estrenes | 1 | 1984 | 2 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1984 | 14 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 1984 | 13 | 0.020 |
Why?
|
| Castration | 1 | 1984 | 13 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1984 | 165 | 0.020 |
Why?
|
| Cytosol | 1 | 1984 | 123 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1984 | 532 | 0.010 |
Why?
|
| Testosterone | 1 | 1984 | 96 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1984 | 282 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1986 | 368 | 0.010 |
Why?
|
| RNA Probes | 2 | 1993 | 15 | 0.010 |
Why?
|
| Pseudopodia | 1 | 2003 | 16 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 27 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 20 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2005 | 291 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 2003 | 35 | 0.010 |
Why?
|
| Sucrose | 1 | 2003 | 58 | 0.010 |
Why?
|
| Microinjections | 1 | 2003 | 130 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1988 | 902 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2003 | 87 | 0.010 |
Why?
|
| United States | 1 | 2015 | 7338 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 289 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2003 | 218 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 524 | 0.010 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2000 | 26 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 1040 | 0.010 |
Why?
|
| Neurotrophin 3 | 1 | 1998 | 7 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1984 | 778 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1998 | 5 | 0.010 |
Why?
|
| Germinoma | 1 | 1997 | 4 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1997 | 16 | 0.010 |
Why?
|
| Hemangioblastoma | 1 | 1997 | 6 | 0.010 |
Why?
|
| Xanthomatosis | 1 | 1997 | 7 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1998 | 118 | 0.010 |
Why?
|
| Keratins | 1 | 1997 | 48 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1998 | 71 | 0.010 |
Why?
|
| Vimentin | 1 | 1997 | 47 | 0.010 |
Why?
|
| Oligodendroglioma | 1 | 1997 | 18 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1997 | 71 | 0.010 |
Why?
|
| Mucin-1 | 1 | 1997 | 35 | 0.010 |
Why?
|
| S100 Proteins | 1 | 1997 | 42 | 0.010 |
Why?
|
| Meningioma | 1 | 1997 | 54 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1997 | 110 | 0.010 |
Why?
|
| Incidence | 1 | 2000 | 1582 | 0.010 |
Why?
|
| Mitogens | 1 | 1993 | 45 | 0.010 |
Why?
|
| Gestational Age | 1 | 1993 | 389 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 1990 | 5 | 0.010 |
Why?
|
| Calcimycin | 1 | 1990 | 32 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1990 | 22 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1990 | 26 | 0.010 |
Why?
|
| Seizures | 1 | 1993 | 279 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1990 | 48 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1990 | 138 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1990 | 66 | 0.010 |
Why?
|
| Troponin C | 1 | 1987 | 2 | 0.000 |
Why?
|
| Introns | 1 | 1987 | 68 | 0.000 |
Why?
|